These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9915046)

  • 1. Economic evaluations applied to HB vaccination: general observations.
    Beutels P
    Vaccine; 1998 Nov; 16 Suppl():S84-92. PubMed ID: 9915046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.
    Aggarwal R; Ghoshal UC; Naik SR
    J Hepatol; 2003 Feb; 38(2):215-22. PubMed ID: 12547411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).
    Beutels P
    Health Econ; 2001 Dec; 10(8):751-74. PubMed ID: 11747055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluations of hepatitis B vaccination for developing countries.
    Tu HA; Woerdenbag HJ; Kane S; Riewpaiboon A; van Hulst M; Postma MJ
    Expert Rev Vaccines; 2009 Jul; 8(7):907-20. PubMed ID: 19538116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
    Beutels P; Edmunds WJ; Antoñanzas F; De Wit GA; Evans D; Feilden R; Fendrick AM; Ginsberg GM; Glick HA; Mast E; Péchevis M; Van Doorslaer EK; van Hout BA;
    Pharmacoeconomics; 2002; 20(1):1-7. PubMed ID: 11817988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M; Detsky AS
    Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board.
    Van Damme P; Kane M; Meheus A
    BMJ; 1997 Apr; 314(7086):1033-6. PubMed ID: 9112852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of hepatitis B vaccination of prison inmates.
    Pisu M; Meltzer MI; Lyerla R
    Vaccine; 2002 Dec; 21(3-4):312-21. PubMed ID: 12450707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
    Kerleau M; Flori YA; Nalpas B; Lanoé JL; Berthelot P; Fardeau-Gautier M
    Rev Epidemiol Sante Publique; 1995; 43(1):48-60. PubMed ID: 7892516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
    Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
    Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on immunization strategies for hepatitis B in different endemic areas of China].
    Wang L; Li H; Wang S; Gong J; Zeng X; Li R; Nong Y; Huang Y; Chen X; Huang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):104-6. PubMed ID: 11864465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
    Ginsberg GM; Berger S; Shouval D
    Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).
    La Torre G; Mannocci A; Saulle R; Colamesta V; Meggiolaro A; Mipatrini D; Sinopoli A
    Hum Vaccin Immunother; 2016 Sep; 12(9):2299-311. PubMed ID: 27105443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
    Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
    Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-benefits of vaccination programmes.
    Szucs T
    Vaccine; 2000 Feb; 18 Suppl 1():S49-51. PubMed ID: 10683547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.